Showing 431-440 of 7422 results for "".
Breakthroughs in Alopecia Areata Treatment
https://practicaldermatology.com/conferences/masterclasses-in-dermatology-2025/breakthroughs-in-alopecia-areata-treatment/33019/Adelaide A. Hebert, MD, chief of pediatric dermatology at the University of Texas Medical School in Houston, talks about her presentation at Masterclasses in Dermatology 2025 discusses breatkthrough treatments for alopecia areata in patients aged 12 and older.A Key to Successful Teen Acne Treatment
https://practicaldermatology.com/topics/acne-rosacea/Key-Successful-Teen-Acne-Treatment/32981/Acne has a significant psychological aspect that affects the quality of life of adolescents. The appearance of acne often causes feelings of shame, reduced self-esteem, anxiety, and even depression in young people. In some cases, it can lead to difficulties in social adaptation and social isolation,Collagen in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/collagen-in-atopic-dermatitis/26997/Dr. Peter Lio and Kripa Ahuja, MS, take a closer look at a 2024 study by Szalus et al. highlighting the importance of collagen in the extracellular matrix, which could potentially serve as a therapeutic target for atopic dermatitis (AD).Meeting Wrap: Dispatches from the RAD and ARM Conferences
https://practicaldermatology.com/conferences/arm-and-rad-meetings-2023/meeting-wrap-dispatches-from-the-rad-and-arm-conferences/24028/The Latest on Acne, Rosacea, and ADThe Secret Sauce for Managing AD
https://practicaldermatology.com/conferences/scale-2023/the-secret-sauce-for-managing-ad/20190/James Del Rosso, DO, discusses new and upcoming therapies for atopic dermatitis including monoclonal antibodies and JAK inhibitors.What Dermatologists Ought to Know About Cyspera®
https://practicaldermatology.com/topics/general-topics/what-dermatologists-ought-to-know-about-cyspera/20103/Cyspera has become a "go-to topical product for pigment," says Michael H. Gold, MD. He describes the Cyspera Intensive System and its benefits for the management of hyperpigmentation. He discusses advancements in the Cyspera formulation that enhance outcomes.Novel Approaches to Nonmelanoma Skin Cancer
https://practicaldermatology.com/topics/skin-cancer-photoprotection/novel-approaches-to-nonmelanoma-skin-cancer/23696/New and emerging treatment options are advancing care for patients with NMSC.DermWireTV: PCA to Space Station; ASDS Pandemic Data; LaRoche-Posay, GW Partnership
https://practicaldermatology.com/topics/practice-management/dermwiretv-pca-to-space-station-asds-pandemic-data-laroche-posay-gw-partnership/20059/The "Great Resignation" forcing some dermatology practices to operate with reduced staffing is just one of the lingering impacts of the COVID-19 pandemic on practices, according to results of a survey by the American Society for Dermatologic Surgery. PCA skin is sending the first-ever private sectorSmart Mouth Approaches
https://practicaldermatology.com/conferences/asds-2021/smart-mouth-approaches/20026/When it comes to managing lines around the mouth, the best interventions may include injectables, devices, or both. Joel L. Cohen, MD discusses his favorite approaches to perioral rejuvenation.DermWireTV: COVID Vaccine Approved; Update on Delta and Dermatology Practice
https://practicaldermatology.com/topics/practice-management/dermwiretv-covid-vaccine-approved-update-on-delta-and-dermatology-practice/19998/FDA approval of Pfizer-BioNTech’s Comirnaty COVID-19 Vaccine comes as Coronavirus case rates surge across the US. We take a look at potential implications for dermatology of the Delta variant spread.